Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($1.19), versus ($1.01) reported last year. Revenue for the quarter came in at $296 thousand, versus $222 thousand reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.